Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-05 COLUMN GROUP L P 10% owner Other disposition −1,000,000 989,000
2021-05-05 COLUMN GROUP L P 10% owner Other acquisition +49,689 49,689
2021-05-05 COLUMN GROUP L P 10% owner Other disposition −49,689 0
2021-05-05 COLUMN GROUP L P 10% owner Other acquisition +17,829 134,010
2021-05-05 COLUMN GROUP L P 10% owner Other acquisition +17,829 139,383
2021-05-05 COLUMN GROUP L P 10% owner Other acquisition +7,752 48,406
2021-05-03 Hansen Gwenn Chief Scientific Officer Exercise or conversion +800 $7.26 $6K 14,604
2021-05-03 Hansen Gwenn Chief Scientific Officer Sale −800 $35.00 $28K 13,804
2021-05-03 Hansen Gwenn Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −800 72,666
2021-04-28 Ring Christine General Counsel Exercise or conversion +800 $1.86 $1K 1,605
2021-04-28 Ring Christine General Counsel Sale −800 $35.25 $28K 805
2021-04-28 Ring Christine General Counsel Exercise or conversion · Employee Stock Option (right to buy) −800 115,666
2021-04-12 Ring Christine General Counsel Exercise or conversion +1,200 $1.86 $2K 2,005
2021-04-12 Ring Christine General Counsel Sale −1,200 $27.20 $33K 805
2021-04-12 Ring Christine General Counsel Exercise or conversion · Employee Stock Option (right to buy) −1,200 116,466
2021-04-12 Beaurang Pierre Chief Business Officer Exercise or conversion +2,396 $0.84 $2K 6,726
2021-04-12 Beaurang Pierre Chief Business Officer Exercise or conversion +5,104 $1.11 $6K 11,830
2021-04-12 Beaurang Pierre Chief Business Officer Sale −4,072 $26.83 $109K 7,758
2021-04-12 Beaurang Pierre Chief Business Officer Sale −2,883 $27.67 $80K 4,875
2021-04-12 Beaurang Pierre Chief Business Officer Sale −545 $28.65 $16K 4,330

Page 36 of 42 · 829 trades